Public Release: 

58 life science researchers elected as new EMBO Members


New EMBO Members are elected annually in recognition of their contributions to scientific excellence. Their selection is a tribute to their research and achievements.

"I am delighted by the addition of 58 outstanding scientists to our membership. I would like to congratulate them and welcome them to the EMBO community", EMBO Director Maria Leptin stated. "By serving the principles of excellence and integrity through their views and actions, they make invaluable contributions to science and society."

The newly elected members and associate members are:

New EMBO Members 2016

  • Adam Antebi
    Max Planck Institute for Biology of Ageing, Cologne, Germany

  • M. Madan Babu
    MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

  • Laure Bally-Cuif
    Institut de Neuroscience Paris-Saclay, Gif-sur-Yvette, Franc, and Institut Pasteur, Paris, France

  • Mohamed Bentires-Alj
    Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland

  • Michael Brand
    Center for Regenerative Therapies, TU Dresden, Germany

  • Dana Branzei
    IFOM, Istituto FIRC, Milan, Italy

  • Frank Buchholz
    UCC, TU Dresden, Germany

  • Ana I. Caño-Delgado
    Centre for Research in Agricultural Genomics, Barcelona, Spain

  • Jason S. Carroll
    Cancer Research UK Cambridge Institute, Cambridge, United Kingdom

  • Andrew P. Carter
    MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

  • Agnieszka Chacinska
    International Institute of Mol. & Cell Biology in Warsaw, Poland

  • Kristina Djinovi?-Carugo
    Max F. Perutz Laboratories, University of Vienna, Austria

  • Óscar Fernández-CapetilloCentro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain, and Karolinska Institute,
    Stockholm, Sweden

  • Darren Gilmour
    EMBL, Heidelberg, Germany

  • Ian A. Graham
    University of York, United Kingdom

  • Manajit Hayer-Hartl
    Max Planck Institute of Biochemistry, Martinsried, Germany

  • Carl-Philipp Heisenberg
    Institute of Science and Technology Austria (IST), Klosterneuburg, Austria

  • István Katona
    Institute of Experimental Medicine of the Hungarian Academy of Sciences, Budapest, Hungary

  • Jan O. Korbel
    EMBL, Heidelberg, Germany

  • Pekka Lappalainen
    University of Helsinki, Finland

  • Helder Maiato
    Instituto de Biologia Molecular e Cellular (IBMC), Porto, Portugal, and Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Portugal

  • Marcos Malumbres
    Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain

  • Fatima Mechta-Grigoriou
    Institut Curie, Paris, France

  • Maria M. Mota
    Instituto de Medicina Molecular, Lisbon, Portugal

  • Daniel J. Müller
    ETH Zurich, Switzerland

  • Eugene Myers
    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

  • Ove Nilsson Swedish University of Agricultural Sciences, Umeå, Sweden

  • Ruth H. Palmer
    Gothenburg University, Sweden

  • Jane E. Parker
    Max Planck Institute for Plant Breeding Research, Köln, Germany

  • Matthieu Piel
    Institut Pierre Gilles de Gennes, Institut Curie/CNRS, PSL University, Paris, France

  • Simona Polo
    IFOM, The FIRC Institute of Molecular Oncology, Milano, Italy

  • Hans-Reimer Redewald
    Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany

  • Claire Rougeole
    CNRS / Université Paris Diderot, Paris, France

  • Raffaella Santoro
    University of Zurich, Switzerland

  • Uwe Sauer
    ETH Zurich, Switzerland

  • Hans R. Scholar
    Max Planck Institute for Molecular Biomedicine, Münster, Germany

  • Melina Schuh
    Max Planck Institute for Biophysical Chemistry, Göttingen, Germany

  • Roberto Solano
    Centro Nacional de Biotecnología (CNB), Madrid, Spain

  • Francois Spitz
    Institut Pasteur, Paris, France

  • Didier Stagner
    Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany

  • Kate G. Storey
    University of Dundee, United Kingdom

  • Peter ten Dijke
    University Medical Centre, Leiden

  • Pavel Tomancak
    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

  • Ian Tomlinson
    Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom

  • Jernej Ule
    The Francis Crick Institute and UCL Institute of Neurology, London, United Kingdom

  • Antonella Viola
    Università di Padova, Italy

  • Douglas J. Winton
    University of Cambridge, Cambridge, United Kingdom

  • Gulnara Yusupova
    Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch, France

  • Xiaodong Zhang
    Imperial College London, United Kingdom

  • Juleen R. Zierath
    Karolinska Institutet, Stockholm, Sweden

New Associate EMBO Members 2016

  • George Fu Gao
    Chinese Academy of Sciences, Beijing, China, and Chinese Center for Disease Control and Prevention, Beijing, China

  • Hiroshi Hamada
    RIKEN Center for Developmental Biology, Kobe, Japan

  • Marc W. Kirchner
    Harvard Medical School, Boston, United States

  • Timothy J. Aitchison
    Harvard Medical School, Boston, United States

  • Huck-Hui Ng
    Genome Institute of Singapore, Singapore

  • Virginijus Siksnys
    Institute of Biotechnology, Vilnius University, Lithuania

  • Hong Wu
    Peking University, Beijing, China

  • Xiaowei Zhuang
    HHMI, Harvard University, Cambridge, United States


An online directory with all existing and new EMBO Members can be found at

About EMBO

EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.

EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. ?For more information:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.